RedHill Biopharma (RDHL) Share-based Compensation (2012 - 2023)
RedHill Biopharma (RDHL) reported Share-based Compensation of $457,000 for the year ended Dec 31, 2025, down 31.3% from $665,000 a year earlier.
Powered by 
Analysis
RedHill Biopharma (RDHL) Share-based Compensation (2012 - 2023) Analysis & Trends
Dating back to the year ended Dec 31, 2010, RedHill Biopharma's Share-based Compensation record includes 16 years.
- Share-based Compensation has declined for four consecutive years, with a five-year compound annual growth rate of -35.8% (years ended Dec 2020 to Dec 2025).
- The figure for the year ended Dec 31, 2025 ranks as the lowest annual Share-based Compensation since the year ended Dec 31, 2010.
- According to Business Quant data, Share-based Compensation came in at $665,000 in the year ended Dec 31, 2024 (-59.6%), $1.65 million in the year ended Dec 31, 2023 (-71.0%), $5.68 million in the year ended Dec 31, 2022 (-44.4%) and $10.21 million in the year ended Dec 31, 2021 (+143.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | - |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 249.00 Mn |
| 10 | RedHill Biopharma | 1.52 Mn | -15.10 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 705,000.00 |
| Mar 31, 2023 | 144,000.00 |
| Dec 31, 2022 | 1.14 Mn |
| Sep 30, 2022 | 1.61 Mn |
| Jun 30, 2022 | 618,000.00 |
| Mar 31, 2022 | 2.31 Mn |
| Dec 31, 2021 | 1.88 Mn |
| Sep 30, 2021 | 2.19 Mn |
| Jun 30, 2021 | 5.27 Mn |
| Mar 31, 2021 | 872,000.00 |
| Dec 31, 2020 | 1.08 Mn |
| Sep 30, 2020 | 1.70 Mn |
| Jun 30, 2020 | 623,000.00 |
| Mar 31, 2020 | 802,000.00 |
| Dec 31, 2019 | 749,000.00 |
| Sep 30, 2019 | 782,000.00 |
| Jun 30, 2019 | 937,000.00 |
| Mar 31, 2019 | 559,000.00 |
| Dec 31, 2018 | 671,000.00 |
| Sep 30, 2018 | 468,000.00 |
API Access
RedHill Biopharma Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();